Effect of topical honey on limitation of radiation-induced oral mucositis: An intervention study

B. Khanal, M. Baliga, N. Uppal

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Radiation therapy for oral carcinoma is therapeutically useful in dose of at least 6000 cGy but causes mucositis that severely interferes with oral function. The literature indicates that honey appears to promote wound healing, so the authors investigated whether its anti-inflammatory properties might limit the severity of radiation-induced oral mucositis. A single-blinded, randomized, controlled clinical trial was carried out to compare the mucositis-limiting qualities of honey with lignocaine. A visual assessment scale permitted scoring of degrees of mucositis and statistical evaluation of the results was performed using the χ2 test. Only 1 of 20 patients in the honey group developed intolerable oral mucositis compared with the lignocaine group, indicating that honey is strongly protective (RR = 0.067) against the development of mucositis. The proportion of patients with intolerable oral mucositis was lower in the honey group and this was statistically significant (p = 0.000). Honey applied topically to the oral mucosa of patients undergoing radiation therapy appears to provide a distinct benefit by limiting the severity of mucositis. Honey is readily available, affordable and well accepted by patients making it useful for improving the quality of life in irradiated patients.

Original languageEnglish
Pages (from-to)1181-1185
Number of pages5
JournalInternational Journal of Oral and Maxillofacial Surgery
Volume39
Issue number12
DOIs
Publication statusPublished - 01-12-2010

Fingerprint

Stomatitis
Honey
Mucositis
Radiation
Lidocaine
Radiotherapy
Mouth Mucosa
Wound Healing
Anti-Inflammatory Agents
Randomized Controlled Trials
Quality of Life
Carcinoma

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oral Surgery
  • Otorhinolaryngology

Cite this

@article{22850488da57438abb5c8a8a57690f5a,
title = "Effect of topical honey on limitation of radiation-induced oral mucositis: An intervention study",
abstract = "Radiation therapy for oral carcinoma is therapeutically useful in dose of at least 6000 cGy but causes mucositis that severely interferes with oral function. The literature indicates that honey appears to promote wound healing, so the authors investigated whether its anti-inflammatory properties might limit the severity of radiation-induced oral mucositis. A single-blinded, randomized, controlled clinical trial was carried out to compare the mucositis-limiting qualities of honey with lignocaine. A visual assessment scale permitted scoring of degrees of mucositis and statistical evaluation of the results was performed using the χ2 test. Only 1 of 20 patients in the honey group developed intolerable oral mucositis compared with the lignocaine group, indicating that honey is strongly protective (RR = 0.067) against the development of mucositis. The proportion of patients with intolerable oral mucositis was lower in the honey group and this was statistically significant (p = 0.000). Honey applied topically to the oral mucosa of patients undergoing radiation therapy appears to provide a distinct benefit by limiting the severity of mucositis. Honey is readily available, affordable and well accepted by patients making it useful for improving the quality of life in irradiated patients.",
author = "B. Khanal and M. Baliga and N. Uppal",
year = "2010",
month = "12",
day = "1",
doi = "10.1016/j.ijom.2010.05.014",
language = "English",
volume = "39",
pages = "1181--1185",
journal = "International Journal of Oral and Maxillofacial Surgery",
issn = "0901-5027",
publisher = "Churchill Livingstone",
number = "12",

}

Effect of topical honey on limitation of radiation-induced oral mucositis : An intervention study. / Khanal, B.; Baliga, M.; Uppal, N.

In: International Journal of Oral and Maxillofacial Surgery, Vol. 39, No. 12, 01.12.2010, p. 1181-1185.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of topical honey on limitation of radiation-induced oral mucositis

T2 - An intervention study

AU - Khanal, B.

AU - Baliga, M.

AU - Uppal, N.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Radiation therapy for oral carcinoma is therapeutically useful in dose of at least 6000 cGy but causes mucositis that severely interferes with oral function. The literature indicates that honey appears to promote wound healing, so the authors investigated whether its anti-inflammatory properties might limit the severity of radiation-induced oral mucositis. A single-blinded, randomized, controlled clinical trial was carried out to compare the mucositis-limiting qualities of honey with lignocaine. A visual assessment scale permitted scoring of degrees of mucositis and statistical evaluation of the results was performed using the χ2 test. Only 1 of 20 patients in the honey group developed intolerable oral mucositis compared with the lignocaine group, indicating that honey is strongly protective (RR = 0.067) against the development of mucositis. The proportion of patients with intolerable oral mucositis was lower in the honey group and this was statistically significant (p = 0.000). Honey applied topically to the oral mucosa of patients undergoing radiation therapy appears to provide a distinct benefit by limiting the severity of mucositis. Honey is readily available, affordable and well accepted by patients making it useful for improving the quality of life in irradiated patients.

AB - Radiation therapy for oral carcinoma is therapeutically useful in dose of at least 6000 cGy but causes mucositis that severely interferes with oral function. The literature indicates that honey appears to promote wound healing, so the authors investigated whether its anti-inflammatory properties might limit the severity of radiation-induced oral mucositis. A single-blinded, randomized, controlled clinical trial was carried out to compare the mucositis-limiting qualities of honey with lignocaine. A visual assessment scale permitted scoring of degrees of mucositis and statistical evaluation of the results was performed using the χ2 test. Only 1 of 20 patients in the honey group developed intolerable oral mucositis compared with the lignocaine group, indicating that honey is strongly protective (RR = 0.067) against the development of mucositis. The proportion of patients with intolerable oral mucositis was lower in the honey group and this was statistically significant (p = 0.000). Honey applied topically to the oral mucosa of patients undergoing radiation therapy appears to provide a distinct benefit by limiting the severity of mucositis. Honey is readily available, affordable and well accepted by patients making it useful for improving the quality of life in irradiated patients.

UR - http://www.scopus.com/inward/record.url?scp=78649684699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649684699&partnerID=8YFLogxK

U2 - 10.1016/j.ijom.2010.05.014

DO - 10.1016/j.ijom.2010.05.014

M3 - Article

C2 - 20832243

AN - SCOPUS:78649684699

VL - 39

SP - 1181

EP - 1185

JO - International Journal of Oral and Maxillofacial Surgery

JF - International Journal of Oral and Maxillofacial Surgery

SN - 0901-5027

IS - 12

ER -